Liquidia (LQDA) Earnings Date & Reports

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

LQDA is expected to report earnings to fall 10.13% to -40 cents per share on May 08

Q1'25

Est.

$-0.40

Q4'24

Missed

by $0.07

Q3'24

Beat

by $0.07

Q2'24

Missed

by $0.03

Q1'24

Missed

by $0.23

The last earnings report on March 19 showed earnings per share of -44 cents, missing the estimate of -38 cents. With 588.56K shares outstanding, the current market capitalization sits at 1.30B.

View a ticker or compare two or three

Compare

LQDA